Status:
COMPLETED
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Breast Cancer
Prostate Cancer
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determi...
Detailed Description
In the United States, consumption of soy products has dramatically increased in the past several years. Foods made from soy are high in isoflavones and evidence suggests that these isoflavones, genist...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Scheduled for prostatectomy
- Willing and able to consume study tablets for at least 2 weeks prior to surgery
- Willing to accept random assignment
- Signed informed consent
- Exclusion Criteria
- Unwilling to avoid soy intake during the study period
- Currently taking antibiotics
Exclusion
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00200824
Start Date
May 1 2000
End Date
January 1 2005
Last Update
March 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christopher Gardner
Stanford, California, United States, 94305-5705